These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 552898)

  • 41. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
    Allen TE; Aliano NA; Cowan RJ; Grigg GW; Hart NK; Lamberton JA; Lane A
    Cancer Res; 1985 Jun; 45(6):2516-21. PubMed ID: 2580623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells.
    Wenzel DG; Morgan DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):279-87. PubMed ID: 6878868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxicity of aniline mustard glucuronide alone or in a combination with glucose in Walker cells in culture and sarcoma-180 tumour bearing animals.
    Deliconstantinos G; Ramantanis G; Todorou DK
    Biomed Pharmacother; 1983; 37(7):339-43. PubMed ID: 6667340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626).
    Laszlo J; Durant J; Loeb V
    Cancer Chemother Rep; 1969 Apr; 53(2):131-4. PubMed ID: 4895097
    [No Abstract]   [Full Text] [Related]  

  • 46. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E; Nichol CA
    Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of different regimens of chemotherapy and x-ray irradiation on the kinetics of experimental tumor growth].
    Parkanskiĭ MI; Konovalova NP; Emanuél' NM
    Vopr Onkol; 1975; 21(10):68-72. PubMed ID: 810969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic activity of mechlorethamine and melphalan against cultured tumor cells: potentiation by caffeine.
    Merriman RL; Sladek NE
    J Pharmacol Exp Ther; 1978 Aug; 206(2):388-97. PubMed ID: 682121
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of Arnebia nobilis and its naphthaquinones in rat Walker carcinosarcoma 256.
    Gupta SK; Mathur IS
    Indian J Cancer; 1972 Mar; 9(1):50-5. PubMed ID: 5044709
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
    No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 52. [Enhancement of Walker-256 antitumor effect by intra-arterial administration of TNF before using mitomycin C].
    Sato T; Sekine S; Katsumi S
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2392-5. PubMed ID: 3137875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
    Schapel GJ; Edwards KD
    J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of hydrazine sulfate on prostate cancer growth.
    Kamradt JM; Pienta KJ
    Oncol Rep; 1998; 5(4):919-21. PubMed ID: 9625846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
    Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
    Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
    [No Abstract]   [Full Text] [Related]  

  • 57. Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells.
    Malvy C; Paoletti C
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):863-5. PubMed ID: 6683654
    [No Abstract]   [Full Text] [Related]  

  • 58. Hydrazine sulfate: a current perspective.
    Gold J
    Nutr Cancer; 1987; 9(2-3):59-66. PubMed ID: 3104888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anabolic profiles in late-stage cancer patients responsive to hydrazine sulfate.
    Gold J
    Nutr Cancer; 1981; 3(1):13-9. PubMed ID: 7050921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor activity of 2,2-hydrazobis(3-chloro-1,4-naphthoquinone) against Walker 256(intramuscular) carcinosarcoma.
    Prescott B
    J Med Chem; 1972 Jan; 15(1):107. PubMed ID: 5007081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.